Co announces it has submitted to the FDA a New Drug Application seeking approval to market a 1100 milligram tablet formulation of balsalazide disodium. Balsalazide disodium is the active ingredient in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results